BRCA2 and melanoma: An increased melanoma risk has been documented in carriers of germline mutations causing other cancer syndromes, including hereditary breast and ovarian cancer (BRCA1/BRCA2), retinoblastoma (RB1), or xeroderma pigmentosum (XPs) [16].